03/13/2015 - 4:30pm

As the editor of Drug Store News, I am frequently reminded that the stories we report on extend far beyond the industry we cover.

03/13/2015 - 12:35pm

An Altarum report found that national health spending increased 5.7% in January 2015 vs. January 2014. 

03/13/2015 - 10:08am

Actavis on Friday announced that the Food and Drug Administration approved Saphris for the treatment of manic or mixed episodes associated with bipolar I disorder in pediatric patients.

03/12/2015 - 11:50am

Drug Channels Institute on Thursday listed the leading specialty pharmacy players. 

03/11/2015 - 1:33pm

A new MIT study published Wednesday suggests that a more powerful H1N1 influenza strain may be making its way through India. 

03/11/2015 - 12:50pm

Mylan expanded its portfolio of generic products with the U.S. launch of buprenorphine hydrochloride sublingual tablets in 2-mg and 8-mg strengths, the generic version of Subutex from Reckitt Benckiser.

03/11/2015 - 12:40pm

Mylan on Wednesday announced the launch of disulfiram tablets USP in dosage strengths of 250 mg and 500 mg.

03/11/2015 - 12:27pm

Mylan launched its fentanyl transdermal system in 37.5-, 62.5- and 87.50-mcg/hr dosage strengths in the United States.

03/10/2015 - 3:52pm

Teva Pharmaceuticals will sell its Sellersville, Penn., facility to G&W Labs. According to Teva, the move supports its mission of streamlining operations by reducing excess manufacturing capacity.